Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1821-1830 of 10643

Edit search filters
  1. ATTR Expanded Access Program (EAP) by Ionis

    Rochester, MN

  2. A Study of the Safety of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Program for use in Stem Cell Transplants to Unrelated People

    Rochester, MN

  3. A Study of a Virtual Reality Module in Adolescents to Retrain their Brain to Make Healthier Choices

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  4. Effect of Coaching on Mid-Career Physician Well-Being, Job Satisfaction, and Fulfillment

  5. A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML

    Rochester, MN

  6. Outcomes after Medial versus Dorsal Approach to Dorsal Cheilectomy for Hallus Rigidus

    Jacksonville, FL

  7. HEMORRHOIDAL EMBOLIZATION TRIAL

    Rochester, MN

  8. Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

    Rochester, MN

  9. Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation

    Rochester, MN

  10. A Study to Evaluate the Effectiveness and Safety of PCS499 in Treating Ulcerations in Patients who have Necrobiosis Lipoidica

    Rochester, MN, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer